Effect of Dapagliflozin on VT in Patients With Heart Failure.
Status:
Not yet recruiting
Trial end date:
2024-11-15
Target enrollment:
Participant gender:
Summary
This project plans to design a randomized controlled clinical trial to evaluate the effect of
dapagliflozin on ventricular arrhythmia in the participants with heart failure with reduced
ejection fraction after ICD implantation by collecting and analyzing the data of ECG, cardiac
ultrasound and ICD programming. This project will explore the anti-ventricular arrhythmia
effect of dapagliflozin in HFrEF patients.
Phase:
Phase 4
Details
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University